Ignite Creation Date:
2024-05-06 @ 11:02 AM
Last Modification Date:
2024-10-26 @ 12:39 PM
Study NCT ID:
NCT03417050
Status:
COMPLETED
Last Update Posted:
2020-01-29
First Post:
2018-01-25
Brief Title:
Synergy Between PCI With TAXUS and Cardiac Surgery SYNTAX Extended Survival
Sponsor:
Erasmus Medical Center
Organization:
Erasmus Medical Center
Study Overview
Official Title:
Synergy Between PCI With TAXUS and Cardiac Surgery SYNTAX Extended Survival
Status:
COMPLETED
Status Verified Date:
2020-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
SYNTAXES
Brief Summary:
An investigator-driven retrospective study to compare long-term survival-data 10-year follow-up of patients with coronary artery disease CAD previously enrolled in the SYNTAX trial who were randomized to percutaneous coronary intervention PCI using a paclitaxel TAXUS drug-eluting-stent DES or coronary artery bypass grafting CABG
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None